The current MNPR market cap is 10.2M. The company's latest EPS is USD -0.5652 and P/E is -1.19.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.41M | -2.91M | -2.53M | -2.33M | -2.07M |
Net Income | -2.4M | -2.89M | -2.44M | -2.2M | -1.95M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 122k | 0 | 0 | 0 |
Operating Income | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
Net Income | -4.23M | -6.31M | -9.1M | -10.5M | -8.4M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.45M | 13.23M | 11.83M | 10.34M | 8.59M |
Total Liabilities | 1.94M | 3.14M | 2.89M | 2.5M | 1.98M |
Total Equity | 12.51M | 10.09M | 8.95M | 7.84M | 6.61M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.35M | 16.87M | 20.52M | 13.23M | 7.35M |
Total Liabilities | 724k | 1.18M | 1.58M | 3.14M | 1.76M |
Total Equity | 12.63M | 15.69M | 18.94M | 10.09M | 5.59M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -5.93M | -7.23M | -2.27M | -4.37M | -6.31M |
Investing | N/A | -4.92M | -983k | 1.97M | 1.96M |
Financing | -106k | 33k | 805k | 1.45M | 1.69M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.02M | -4.66M | -7.32M | -7.23M | -7.86M |
Investing | N/A | N/A | N/A | -4.92M | 4.93M |
Financing | 9.35M | 8.18M | 10.88M | 33k | 2.03M |
Market Cap | 10.2M |
Price to Earnings Ratio | -1.19 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.37 |
Price to Book Ratio | 1.78 |
Dividend Yield | - |
Shares Outstanding | 14.87M |
Average Volume (1 week) | 308.32k |
Average Volume (1 Month) | 204.48k |
52 Week Change | -45.12% |
52 Week High | 1.75 |
52 Week Low | 0.2739 |
Spread (Intraday) | 0.01 (1.88%) |
Company Name | Monopar Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.monopartx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.